Last Updated:
Shares of Inventurus Knowledge Solutions listed with a premium of nearly 43 per cent against the issue price of Rs 1,329 on Thursday.
Inventurus Knowledge Solutions Share Price: Opened at Rs 1,856, marking a 39.65% rally from the issue price, and later surged 46.13% to Rs 1,942.10.
Shares of Inventurus Knowledge Solutions Ltd, a provider of healthcare support services, made an impressive debut on Thursday, listing with a 43% premium over the issue price of Rs 1,329.
Inventurus Knowledge Solutions Share Price Today
Stock Performance on Listing Day
- BSE Listing: Opened at Rs 1,856, marking a 39.65% rally from the issue price, and later surged 46.13% to Rs 1,942.10.
- NSE Listing: Debuted at Rs 1,900, reflecting a 42.96% jump.
- Market Valuation: The company’s market cap reached Rs 32,282.35 crore.
IPO Details and Strong Subscription
- Issue Size: Rs 2,498 crore.
- Price Band: Rs 1,265-1,329 per share.
- Subscription: The IPO received 52.68 times subscription on its closing day.
- Offer For Sale (OFS): The IPO was entirely an OFS of 1.88 crore equity shares by promoters and individual shareholders, with no fresh issue component.
- Proceeds: As the issue was fully an OFS, the company will not receive any proceeds, and the entire amount will go to the selling shareholders.
Objectives Behind the IPO
Inventurus Knowledge Solutions stated in its IPO documents that the primary objectives of the share sale were:
- Gaining advantages of listing equity shares on stock exchanges.
- Enhancing visibility and brand image.
- Providing liquidity to existing shareholders.
- Establishing a public market for its equity shares.
About Inventurus Knowledge Solutions
Inventurus Knowledge Solutions Ltd is a technology-enabled healthcare solutions provider focused on care enablement. The company assists physician enterprises primarily in the US, Canada, and Australia, with a strong emphasis on the US market.
Client Base: Serves over 800 healthcare organisations, including health systems, academic medical centres, multi-specialty and single-specialty medical groups, as well as ancillary healthcare organisations.
Backers: The company is supported by Rekha Jhunjhunwala and RARE Enterprises.
The strong market debut underscores investor confidence in the company’s healthcare-centric solutions and its growth potential in international markets.
